HBOT is an effective treatment for Lyme disease. Because it provides over 1000 times the normal amount of oxygen at increased pressure, it restores many body functions, especially including the immune system.
Borrelia burgdorferi, the strain of bacteria that causes Lyme disease in the US, is an anaerobe and therefore cannot survive in an oxygen-rich environment. As HBOT therapy increases the amount of oxygen in the body, it causes bacterial spirochetes to die off. When antibiotics are combined with HBOT, the effectiveness of antibiotics to combat the Lyme organism is increased as the medication is pushed deep into the body, attacking the spirochetes.
HBOT also acts as an immune modulator and allows organ and gland functionality to normalize, reducing many of the debilitating Lyme symptoms. Because the chambers pressurize the atmosphere, HBOT acts as a detoxifier by increasing the oxygen pressure, forcing oxygen into the tissues while pushing toxins and chemicals out.
Just as with antibiotic treatment, HBOT may cause a Jarish-Herxheimer reaction (known as “Herxing”) after the first treatment. This reaction is the result of the Borelia burgdorferi dying off. Patients may briefly experience fever, chills and fatigue. These symptoms go away after a few treatments and generally indicate that HBOT is working.
Benefits of HBOT for Lyme disease include
Restored cognitive function
Normalization of organs and glands
Removal of toxins and other impurities
Overview of Lyme disease and HBOT
Positive effects of HBOT on Lyme-related encephalopathy
HBOT as an effective treatment for chronic Lyme disease